Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 189 | $174,889,208 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 14 Feb 2025 19:13 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 13 Feb 2025 | Sale | 796 | 116.7664 | 92,946 | D |
| 14 Feb 2025 19:13 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 13 Feb 2025 | Sale | 755 | 116.7988 | 88,183 | D |
| 14 Feb 2025 18:57 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 13 Feb 2025 | Sale | 2,832 | 116.6895 | 330,465 | D |
| 14 Feb 2025 18:57 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 13 Feb 2025 | Sale | 3,012 | 116.6832 | 351,450 | D |
| 14 Feb 2025 18:49 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 13 Feb 2025 | Sale | 13,831 | 116.6888 | 1,613,923 | D |
| 14 Feb 2025 18:42 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 13 Feb 2025 | Sale | 1,114 | 116.9049 | 130,232 | D |
| 14 Feb 2025 18:42 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 13 Feb 2025 | Sale | 604 | 116.7391 | 70,510 | D |
| 14 Feb 2025 18:42 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 14 Feb 2025 | Sale | 500 | 115.0425 | 57,521 | D |
| 14 Feb 2025 18:35 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 13 Feb 2025 | Sale | 1,432 | 116.8335 | 167,306 | D |
| 14 Feb 2025 18:35 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 13 Feb 2025 | Sale | 1,447 | 116.7471 | 168,933 | D |
| 14 Feb 2025 18:26 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 13 Feb 2025 | Sale | 1,098 | 116.76 | 128,202 | D |
| 14 Feb 2025 18:26 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 13 Feb 2025 | Sale | 1,086 | 116.7495 | 126,790 | D |
| 14 Feb 2025 18:20 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Executive Officer | 13 Feb 2025 | Sale | 1,352 | 116.8448 | 157,974 | D |
| 14 Feb 2025 18:20 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Executive Officer | 13 Feb 2025 | Sale | 1,206 | 116.8606 | 140,934 | D |
| 14 Feb 2025 18:13 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 13 Feb 2025 | Sale | 716 | 116.6892 | 83,549 | D |
| 14 Feb 2025 18:13 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 13 Feb 2025 | Sale | 755 | 116.7214 | 88,125 | D |
| 14 Feb 2025 18:08 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 13 Feb 2025 | Sale | 955 | 116.7939 | 111,538 | D |
| 14 Feb 2025 18:08 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 13 Feb 2025 | Sale | 830 | 116.6857 | 96,849 | D |
| 14 Feb 2025 18:03 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 13 Feb 2025 | Sale | 1,098 | 116.7421 | 128,183 | D |
| 14 Feb 2025 18:03 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 13 Feb 2025 | Sale | 1,056 | 116.7091 | 123,245 | D |
| 14 Feb 2025 18:00 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 13 Feb 2025 | Sale | 1,352 | 116.8487 | 157,979 | D |
| 14 Feb 2025 18:00 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 13 Feb 2025 | Sale | 1,206 | 116.8688 | 140,944 | D |
| 12 Feb 2025 19:00 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 10 Feb 2025 | Sale | 700 | 118.275 | 82,792 | D |
| 12 Feb 2025 18:56 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 10 Feb 2025 | Sale | 2,274 | 118.3673 | 269,167 | D |
| 12 Feb 2025 18:52 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 10 Feb 2025 | Sale | 980 | 118.217 | 115,853 | D |
| 12 Feb 2025 18:49 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 10 Feb 2025 | Sale | 911 | 118.2514 | 107,727 | D |
| 12 Feb 2025 18:48 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Executive Officer | 10 Feb 2025 | Sale | 980 | 118.3881 | 116,020 | D |
| 12 Feb 2025 18:46 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 10 Feb 2025 | Sale | 700 | 118.3144 | 82,820 | D |
| 12 Feb 2025 18:44 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 10 Feb 2025 | Sale | 980 | 118.3065 | 115,940 | D |
| 12 Feb 2025 18:41 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 10 Feb 2025 | Sale | 980 | 118.274 | 115,909 | D |
| 04 Feb 2025 18:05 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 31 Jan 2025 | Sale | 916 | 152.8879 | 140,045 | D |
| 04 Feb 2025 18:05 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 31 Jan 2025 | Sale | 824 | 152.8879 | 125,980 | D |
| 04 Feb 2025 17:58 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 31 Jan 2025 | Sale | 2,707 | 152.9246 | 413,967 | D |
| 04 Feb 2025 17:54 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 31 Jan 2025 | Sale | 1,457 | 152.8045 | 222,636 | D |
| 04 Feb 2025 17:51 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 31 Jan 2025 | Sale | 126 | 152.9681 | 19,274 | D |
| 04 Feb 2025 17:49 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 31 Jan 2025 | Sale | 1,250 | 152.9064 | 191,133 | D |
| 04 Feb 2025 17:47 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Executive Officer | 31 Jan 2025 | Sale | 1,541 | 152.8731 | 235,577 | D |
| 04 Feb 2025 17:45 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 31 Jan 2025 | Sale | 422 | 153.0491 | 64,587 | D |
| 04 Feb 2025 17:45 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 03 Feb 2025 | Sale | 623 | 149.29 | 93,008 | D |
| 04 Feb 2025 17:42 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 31 Jan 2025 | Sale | 1,104 | 152.9433 | 168,849 | D |
| 04 Feb 2025 17:35 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 31 Jan 2025 | Sale | 1,207 | 152.94 | 184,599 | D |
| 04 Feb 2025 17:31 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 31 Jan 2025 | Sale | 1,283 | 152.8728 | 196,136 | D |
| 29 Jan 2025 19:03 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 27 Jan 2025 | Sale | 146,105 | 149.4576 | 21,836,503 | D |
| 17 Jan 2025 16:32 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Executive Officer | 15 Jan 2025 | Sale | 4,812 | 141.4991 | 680,894 | D |
| 17 Jan 2025 16:32 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Executive Officer | 15 Jan 2025 | Sale | 60,188 | 141.5009 | 8,516,656 | D |
| 03 Jan 2025 16:23 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 31 Dec 2024 | Sale | 272 | 138.1 | 37,563 | D |
| 19 Dec 2024 16:37 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 17 Dec 2024 | Sale | 1,091 | 135 | 147,285 | D |
| 03 Dec 2024 18:52 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 29 Nov 2024 | Sale | 2,331 | 126.286 | 294,373 | D |
| 07 Oct 2024 16:33 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 03 Oct 2024 | Sale | 1,295 | 113.66 | 147,190 | D |
| 17 Sep 2024 16:21 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 13 Sep 2024 | Sale | 3,461 | 121.8804 | 421,828 | D |
| 16 Aug 2024 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | 15 Aug 2024 | Sale | 14,250 | 146.69 | 2,090,332 | D |
| 15 Aug 2024 17:21 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 13 Aug 2024 | Sale | 11,570 | 150.4278 | 1,740,450 | D |
| 15 Aug 2024 17:12 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 13 Aug 2024 | Sale | 14,100 | 150.3792 | 2,120,347 | D |
| 15 Aug 2024 17:06 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 13 Aug 2024 | Sale | 4,100 | 150.0813 | 615,333 | D |
| 15 Aug 2024 17:06 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 13 Aug 2024 | Sale | 3,043 | 150.1305 | 456,847 | D |
| 08 Aug 2024 17:16 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 06 Aug 2024 | Sale | 273 | 147.7 | 40,322 | D |
| 05 Aug 2024 17:40 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 01 Aug 2024 | Sale | 12,632 | 153.2629 | 1,936,017 | D |
| 05 Aug 2024 17:18 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 01 Aug 2024 | Sale | 2,996 | 154.013 | 461,423 | D |
| 18 Jul 2024 17:12 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 16 Jul 2024 | Sale | 900 | 150.04 | 135,036 | D |
| 18 Jul 2024 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 16 Jul 2024 | Sale | 900 | 150.04 | 135,036 | D |
| 18 Jul 2024 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 16 Jul 2024 | Sale | 1,557 | 150 | 233,550 | D |
| 18 Jul 2024 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 16 Jul 2024 | Sale | 400 | 150.1025 | 60,041 | D |
| 18 Jul 2024 16:54 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 16 Jul 2024 | Sale | 930 | 150.0325 | 139,530 | D |
| 18 Jul 2024 16:45 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 16 Jul 2024 | Sale | 900 | 150.0411 | 135,037 | D |
| 18 Jul 2024 16:41 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 16 Jul 2024 | Sale | 7,004 | 149.9986 | 1,050,590 | D |
| 02 Jul 2024 21:36 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 01 Jul 2024 | Sale | 10,000 | 140.1864 | 1,401,864 | D |
| 02 Jul 2024 21:09 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 01 Jul 2024 | Sale | 272 | 138.11 | 37,566 | D |
| 04 Jun 2024 16:23 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 31 May 2024 | Sale | 273 | 136.55 | 37,278 | D |
| 30 May 2024 16:38 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 29 May 2024 | Sale | 15,000 | 133.4673 | 2,002,010 | D |
| 30 May 2024 16:38 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 29 May 2024 | Sale | 25,000 | 133.4622 | 3,336,555 | D |
| 21 May 2024 17:35 | NBIX | NEUROCRINE BIOSCIENCES INC | SHARP SHALINI | Director | 17 May 2024 | Sale | 1,106 | 141.9018 | 156,943 | D |
| 21 May 2024 17:27 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 17 May 2024 | Sale | 2,100 | 141.8383 | 297,860 | D |
| 21 May 2024 17:06 | NBIX | NEUROCRINE BIOSCIENCES INC | NORWALK LESLIE V | Director | 17 May 2024 | Sale | 1,106 | 141.8173 | 156,850 | D |
| 16 May 2024 16:55 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 14 May 2024 | Sale | 12,500 | 135.6296 | 1,695,370 | D |
| 16 May 2024 16:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 15 May 2024 | Sale | 15,000 | 140.2406 | 2,103,609 | D |
| 16 May 2024 16:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 14 May 2024 | Sale | 15,000 | 135.6551 | 2,034,826 | D |
| 08 May 2024 16:26 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 06 May 2024 | Sale | 273 | 140.55 | 38,370 | D |
| 17 Apr 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 15 Apr 2024 | Sale | 12,587 | 133.3646 | 1,678,660 | D |
| 17 Apr 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 15 Apr 2024 | Sale | 7,231 | 133.3646 | 964,359 | D |
| 03 Apr 2024 16:44 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 01 Apr 2024 | Sale | 272 | 137.3 | 37,346 | D |
| 25 Mar 2024 18:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 21 Mar 2024 | Sale | 5,000 | 145.064 | 725,320 | D |
| 15 Mar 2024 17:33 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 14 Mar 2024 | Sale | 69,521 | 139.3789 | 9,689,761 | D |
| 15 Mar 2024 17:33 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 14 Mar 2024 | Sale | 5,479 | 139.3789 | 763,657 | D |
| 15 Mar 2024 17:25 | NBIX | NEUROCRINE BIOSCIENCES INC | MORROW GEORGE J | Director | 14 Mar 2024 | Sale | 20,000 | 139.4139 | 2,788,278 | D |
| 15 Mar 2024 17:25 | NBIX | NEUROCRINE BIOSCIENCES INC | MORROW GEORGE J | Director | 14 Mar 2024 | Sale | 20,000 | 139.4216 | 2,788,432 | D |
| 15 Mar 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 13 Mar 2024 | Sale | 23,200 | 140.3285 | 3,255,621 | D |
| 15 Mar 2024 17:15 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 13 Mar 2024 | Sale | 3,000 | 140.1398 | 420,419 | D |
| 12 Mar 2024 18:47 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 11 Mar 2024 | Sale | 100 | 140 | 14,000 | D |
| 12 Mar 2024 18:47 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 08 Mar 2024 | Sale | 1,700 | 140.0459 | 238,078 | D |
| 12 Mar 2024 18:38 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 11 Mar 2024 | Sale | 200 | 140 | 28,000 | D |
| 12 Mar 2024 18:38 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 08 Mar 2024 | Sale | 1,800 | 140.0292 | 252,053 | D |
| 29 Feb 2024 19:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 29 Feb 2024 | Sale | 273 | 135.51 | 36,994 | D |
| 29 Feb 2024 19:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 28 Feb 2024 | Sale | 1,544 | 136 | 209,984 | D |
| 29 Feb 2024 19:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 28 Feb 2024 | Sale | 2,500 | 134.62 | 336,550 | D |
| 29 Feb 2024 19:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 28 Feb 2024 | Sale | 2,500 | 135.6414 | 339,104 | D |
| 29 Feb 2024 18:55 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 28 Feb 2024 | Sale | 21,857 | 134.6881 | 2,943,878 | D |
| 29 Feb 2024 18:55 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 28 Feb 2024 | Sale | 53,143 | 134.6881 | 7,157,730 | D |
| 29 Feb 2024 18:50 | NBIX | NEUROCRINE BIOSCIENCES INC | NORWALK LESLIE V | Director | 27 Feb 2024 | Sale | 8,000 | 135.6735 | 1,085,388 | D |
| 22 Feb 2024 17:11 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 20 Feb 2024 | Sale | 15,000 | 132.4698 | 1,987,047 | D |
| 15 Feb 2024 17:51 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 13 Feb 2024 | Sale | 1,114 | 132.9639 | 148,122 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)